Ernexa Therapeutics Inc. - Common Stock (ERNA)

0.2657
-0.0043 (-1.59%)
NASDAQ · Last Trade: Mar 22nd, 11:46 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
8 MAGA $1 Stocks: PRSO, GXAI, SURG, DVLT – See More Inside
The search for stocks under $1, penny stocks with momentum , and micro-cap growth opportunities continues to trend across retail trading platforms and AI-driven discovery engines. As market volatility increases and investors look for asymmetric upside potential, several sub-$1 equities are drawing heightened attention due to sector positioning, news catalysts, and unusual trading activity.
Via AB Newswire · February 17, 2026
Synergy (NASDAQ: SNYR) CEO Jack Ross at NASDAQ Discusses FOCUSfactor® Beverage Production, Rollout, and Expansion – Watch Now! – More Stocks Inside
Synergy CHC Corp. (NASDAQ: SNYR), a leading consumer health and wellness company, announced continued momentum for its flagship brand FOCUSfactor® following several key milestones and retail expansions across North America, UK, UAE, Turkey and Latin America.
Via AB Newswire · October 29, 2025
In a New Audio Interview, Toni Loudenbeck of Traders News Source Interviews Dr. Matt Angel, CEO Eterna Therapeutics
NEW YORK, NY / ACCESSWIRE / December 20, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap publicly traded companies recently issued a new C-Level interview with Eterna Therapeutics.
Via ACCESSWIRE · December 20, 2022